Literature DB >> 25308307

Wall-eyed bilateral internuclear ophthalmoplegia: review of pathogenesis, diagnosis, prognosis and management.

Yu-Tai Wu1, Malinda Cafiero-Chin, Cathy Marques.   

Abstract

Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) is an uncommon disorder of ocular motility that possesses a unique spectrum of clinical findings, consisting of primary gaze exotropia, adduction impairment and nystagmus of the abducting eye. WEBINO is a variant of internuclear ophthalmoplegia (INO) sharing similar pathophysiology and aetiologies. Much of the literature published on internuclear ophthalmoplegia and its variants focuses on aetiology and pathophysiology, whereas there has been less information addressing prognosis and management. This review will provide current perspectives on the pathogenesis, prognosis and management of WEBINO syndrome.
© 2014 The Authors. Clinical and Experimental Optometry © 2014 Optometrists Association Australia.

Entities:  

Keywords:  abducens nucleus; brainstem infarction; diplopia; exotropia; extraocular muscle surgery; internuclear ophthalmoplegia; medial longitudinal fasciculus; multiple sclerosis; nystagmus; ocular motility; paramedian pontine reticular formation

Mesh:

Year:  2014        PMID: 25308307     DOI: 10.1111/cxo.12200

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  10 in total

1.  Can Wernekink commissure syndrome and wall-eyed bilateral internuclear ophthalmoplegia be ascribed to neuromyelitis optica spectrum disorder?

Authors:  Zhangyu Zou; Weian Chen
Journal:  Neurol Sci       Date:  2017-07-05       Impact factor: 3.307

2.  Transposition surgery for WEBINO.

Authors:  Marjan Sajjadi; Seyed Ali Sonbolestan; Seyed Mohammad Ali Abtahi; Zahra Sadat Abtahi
Journal:  Int Ophthalmol       Date:  2016-04-20       Impact factor: 2.031

3.  Isolated bilateral internuclear ophthalmoplegia due to lacunar infarction.

Authors:  Zhao Jiang; Wenhong Wang
Journal:  Neurol Sci       Date:  2017-11-23       Impact factor: 3.307

4.  Caudal paramedian midbrain infarction: a clinical study of imaging, clinical features and stroke mechanisms.

Authors:  Chenguang Zhou; Zhiqiang Xu; Botao Huang; Yuanhong He; Yinghui Zhu; Yuanzheng Zhao; Peng Wang
Journal:  Acta Neurol Belg       Date:  2019-08-27       Impact factor: 2.396

5.  In Reply.

Authors:  Stephan Petrik; Johann Lambeck; Jürgen Bardutzky
Journal:  Dtsch Arztebl Int       Date:  2022-04-22       Impact factor: 8.251

6.  Bilateral INO in PSP.

Authors:  Harsh V Gupta; Kayla Karlowski; Thomas J Whittaker
Journal:  Ann Indian Acad Neurol       Date:  2020-02-25       Impact factor: 1.383

Review 7.  Development of a core outcome set for amblyopia, strabismus and ocular motility disorders: a review to identify outcome measures.

Authors:  Samia Al Jabri; Jamie Kirkham; Fiona J Rowe
Journal:  BMC Ophthalmol       Date:  2019-02-08       Impact factor: 2.209

8.  When "looks" can be deceiving - Internuclear ophthalmoplegia after mild traumatic brain injury: Case report and literature review.

Authors:  Shaikh Hai; Adel Elkbuli; Kyle Kinslow; Mark McKenney; Dessy Boneva
Journal:  Int J Surg Case Rep       Date:  2019-09-11

9.  Bilateral Internuclear Ophthalmoplegia in a Young Woman with Vertebral Artery Dissection.

Authors:  Omar Cárdenas; Enrique Gomez; Mariana Marcín; Adib Jorge de Sarachaga; Verónica Sánchez; Juan Manuel Calleja
Journal:  Eur J Case Rep Intern Med       Date:  2019-06-12

10.  Rare case of chemotherapy-refractory metastatic vaginal squamous cell carcinoma with complete response to concurrent pembrolizumab and radiotherapy- case report and literature review.

Authors:  Jawaher Ansari; Yussra Eltigani Mohmmed; Saad Ghazal-Aswad; Hidayath Ansari; Syed M J Akhter; Omar Hassoun Hadid; Syed Rizwan; Raya Almazrouei; Emad Dawoud; Fathi Azribi; Heba Elhasin; Pawan Kumar; Abdul Rahman Al Sumaida; Khaled Al-Qawasmeh; John Glaholm; M J Hochmair; Syed Hussain; Khalid Balaraj
Journal:  Gynecol Oncol Rep       Date:  2021-10-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.